|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.KR |
First Approval Date26 Aug 2024 |
100 Clinical Results associated with Jeil Health Science, Inc.
0 Patents (Medical) associated with Jeil Health Science, Inc.
100 Deals associated with Jeil Health Science, Inc.
100 Translational Medicine associated with Jeil Health Science, Inc.